PLX icon

Protalix BioTherapeutics
PLX

Overview Fund Activity

27 hedge funds and large institutions have $3.7M invested in Protalix BioTherapeutics in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 5 closing their positions.

Holders
27
Holders Change
-3
Holders Change %
-10%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
7
Closed
5
Calls
$988K
Puts
$110K
Net Calls
+$878K
Net Calls Change
-$535K

Top Buyers

1
HCM
1
Highbridge Capital Management
New York
$2.51M
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$231K
3
UBS Group
3
UBS Group
Switzerland
$11K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$122K
5
ACA
5
Aptus Capital Advisors
Alabama
$15K

Top Sellers

1
SWM
1
Spire Wealth Management
Virginia
$0
2
Two Sigma Advisers
2
Two Sigma Advisers
New York
$26K
3
VF
3
Virtu Financial
New York
$0
4
BCM
4
Bridgeway Capital Management
Texas
$139K
5
Millennium Management
5
Millennium Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
FDCDDQ
26
Federation des caisses Desjardins du Quebec
Quebec, Canada
$260 250 – –
SWM
27
Spire Wealth Management
Virginia
– – -148,800 Closed
VF
28
Virtu Financial
New York
– – -28,816 Closed
Millennium Management
29
Millennium Management
New York
– – -19,223 Closed
CAPTRUST Financial Advisors
30
CAPTRUST Financial Advisors
North Carolina
– – -800 Closed
JPMorgan Chase & Co
31
JPMorgan Chase & Co
New York
– – -395 Closed
CFGS
32
Concourse Financial Group Securities
Alabama
– – – –
Wolverine Trading
33
Wolverine Trading
Illinois
– – – –
Group One Trading
34
Group One Trading
Illinois
– – – –
Simplex Trading
35
Simplex Trading
Illinois
– – – –
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$0 373 +358 +2,387%
1
2